|
US2010179214A1
|
|
Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders
|
|
US2010179215A1
|
|
Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders
|
|
CA2721133A1
|
|
Low-dose doxepin formulations and methods of making and using the same
|
|
US2009042971A1
|
|
Method of using low-dose doxepin for the improvement of sleep
|
|
US2009042972A1
|
|
Methods of using low-dose doxepin for the improvement of sleep
|
|
US2011077200A1
|
|
Combination therapy using low-dose doxepin for the improvement of sleep
|
|
US2010105614A1
|
|
Ultra low dose doxepin and methods of using the same to treat sleep disorders
|
|
WO2008085567A1
|
|
Methods of using low-dose doxepin for the improvement of sleep
|
|
WO2008011150A1
|
|
Methods of improving the pharmacokinetics of doxepin
|
|
WO2007142810A2
|
|
Methods of using low-dose doxepin for the improvement of sleep
|
|
WO2007136741A2
|
|
N-desmethyl-doxepin and methods of using the same to treat sleep disorders
|
|
WO2007136845A2
|
|
Low-dose doxepin for treatment of sleep disorders in elderly patients
|
|
CA2687124A1
|
|
Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomnia
|
